Global Human Microbiome Modulators Market Research Report 2023

The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.

The global Human Microbiome Modulators market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Human Microbiome Modulators is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Human Microbiome Modulators is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Human Microbiome Modulators in Digestive Health is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Human Microbiome Modulators include Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM and Lallemand, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Human Microbiome Modulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Modulators.

The Human Microbiome Modulators market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Microbiome Modulators market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Microbiome Modulators companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Microbiome Modulators Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Probiotics and Creams

1.2.3 Prebiotics and Dietary Supplements

1.2.4 Drugs

1.3 Market by Application

1.3.1 Global Human Microbiome Modulators Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Digestive Health

1.3.3 Immune Health

1.3.4 Oral Health

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Human Microbiome Modulators Market Perspective (2018-2029)

2.2 Human Microbiome Modulators Growth Trends by Region

2.2.1 Global Human Microbiome Modulators Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Human Microbiome Modulators Historic Market Size by Region (2018-2023)

2.2.3 Human Microbiome Modulators Forecasted Market Size by Region (2024-2029)

2.3 Human Microbiome Modulators Market Dynamics

2.3.1 Human Microbiome Modulators Industry Trends

2.3.2 Human Microbiome Modulators Market Drivers

2.3.3 Human Microbiome Modulators Market Challenges

2.3.4 Human Microbiome Modulators Market Restraints

3.1 Global Top Human Microbiome Modulators Players by Revenue

3.1.1 Global Top Human Microbiome Modulators Players by Revenue (2018-2023)

3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2018-2023)

3.2 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Human Microbiome Modulators Revenue

3.4 Global Human Microbiome Modulators Market Concentration Ratio

3.4.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2022

3.5 Human Microbiome Modulators Key Players Head office and Area Served

3.6 Key Players Human Microbiome Modulators Product Solution and Service

3.7 Date of Enter into Human Microbiome Modulators Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Human Microbiome Modulators Historic Market Size by Type (2018-2023)

4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2024-2029)

5.1 Global Human Microbiome Modulators Historic Market Size by Application (2018-2023)

5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2024-2029)

6.1 North America Human Microbiome Modulators Market Size (2018-2029)

6.2 North America Human Microbiome Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Human Microbiome Modulators Market Size by Country (2018-2023)

6.4 North America Human Microbiome Modulators Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Human Microbiome Modulators Market Size (2018-2029)

7.2 Europe Human Microbiome Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Human Microbiome Modulators Market Size by Country (2018-2023)

7.4 Europe Human Microbiome Modulators Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Human Microbiome Modulators Market Size (2018-2029)

8.2 Asia-Pacific Human Microbiome Modulators Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Human Microbiome Modulators Market Size by Region (2018-2023)

8.4 Asia-Pacific Human Microbiome Modulators Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Human Microbiome Modulators Market Size (2018-2029)

9.2 Latin America Human Microbiome Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Human Microbiome Modulators Market Size by Country (2018-2023)

9.4 Latin America Human Microbiome Modulators Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Human Microbiome Modulators Market Size (2018-2029)

10.2 Middle East & Africa Human Microbiome Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Human Microbiome Modulators Market Size by Country (2018-2023)

10.4 Middle East & Africa Human Microbiome Modulators Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Bayer

11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Human Microbiome Modulators Introduction

11.1.4 Bayer Revenue in Human Microbiome Modulators Business (2018-2023)

11.1.5 Bayer Recent Development

11.2 BioGaia

11.2.1 BioGaia Company Detail

11.2.2 BioGaia Business Overview

11.2.3 BioGaia Human Microbiome Modulators Introduction

11.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2018-2023)

11.2.5 BioGaia Recent Development

11.3 Chr. Hansen Holding

11.3.1 Chr. Hansen Holding Company Detail

11.3.2 Chr. Hansen Holding Business Overview

11.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction

11.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2018-2023)

11.3.5 Chr. Hansen Holding Recent Development

11.4 DowDuPont

11.4.1 DowDuPont Company Detail

11.4.2 DowDuPont Business Overview

11.4.3 DowDuPont Human Microbiome Modulators Introduction

11.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2018-2023)

11.4.5 DowDuPont Recent Development

11.5 Ingredion

11.5.1 Ingredion Company Detail

11.5.2 Ingredion Business Overview

11.5.3 Ingredion Human Microbiome Modulators Introduction

11.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2018-2023)

11.5.5 Ingredion Recent Development

11.6 ISOThrive

11.6.1 ISOThrive Company Detail

11.6.2 ISOThrive Business Overview

11.6.3 ISOThrive Human Microbiome Modulators Introduction

11.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2018-2023)

11.6.5 ISOThrive Recent Development

11.7 Jarrow Formulas

11.7.1 Jarrow Formulas Company Detail

11.7.2 Jarrow Formulas Business Overview

11.7.3 Jarrow Formulas Human Microbiome Modulators Introduction

11.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2018-2023)

11.7.5 Jarrow Formulas Recent Development

11.8 DSM

11.8.1 DSM Company Detail

11.8.2 DSM Business Overview

11.8.3 DSM Human Microbiome Modulators Introduction

11.8.4 DSM Revenue in Human Microbiome Modulators Business (2018-2023)

11.8.5 DSM Recent Development

11.9 Lallemand

11.9.1 Lallemand Company Detail

11.9.2 Lallemand Business Overview

11.9.3 Lallemand Human Microbiome Modulators Introduction

11.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2018-2023)

11.9.5 Lallemand Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Detail

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Human Microbiome Modulators Introduction

11.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2018-2023)

11.10.5 Sanofi Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Human Microbiome Modulators Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Probiotics and Creams

    Table 3. Key Players of Prebiotics and Dietary Supplements

    Table 4. Key Players of Drugs

    Table 5. Global Human Microbiome Modulators Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Human Microbiome Modulators Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Human Microbiome Modulators Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Human Microbiome Modulators Market Share by Region (2018-2023)

    Table 9. Global Human Microbiome Modulators Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Human Microbiome Modulators Market Share by Region (2024-2029)

    Table 11. Human Microbiome Modulators Market Trends

    Table 12. Human Microbiome Modulators Market Drivers

    Table 13. Human Microbiome Modulators Market Challenges

    Table 14. Human Microbiome Modulators Market Restraints

    Table 15. Global Human Microbiome Modulators Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Human Microbiome Modulators Market Share by Players (2018-2023)

    Table 17. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2022)

    Table 18. Ranking of Global Top Human Microbiome Modulators Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Human Microbiome Modulators Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Human Microbiome Modulators Product Solution and Service

    Table 22. Date of Enter into Human Microbiome Modulators Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Human Microbiome Modulators Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Human Microbiome Modulators Revenue Market Share by Type (2018-2023)

    Table 26. Global Human Microbiome Modulators Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Human Microbiome Modulators Revenue Market Share by Type (2024-2029)

    Table 28. Global Human Microbiome Modulators Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Human Microbiome Modulators Revenue Market Share by Application (2018-2023)

    Table 30. Global Human Microbiome Modulators Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Human Microbiome Modulators Revenue Market Share by Application (2024-2029)

    Table 32. North America Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Human Microbiome Modulators Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Human Microbiome Modulators Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Human Microbiome Modulators Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Human Microbiome Modulators Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Human Microbiome Modulators Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Human Microbiome Modulators Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Human Microbiome Modulators Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Human Microbiome Modulators Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Human Microbiome Modulators Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Human Microbiome Modulators Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Human Microbiome Modulators Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Human Microbiome Modulators Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Bayer Company Detail

    Table 48. Bayer Business Overview

    Table 49. Bayer Human Microbiome Modulators Product

    Table 50. Bayer Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 51. Bayer Recent Development

    Table 52. BioGaia Company Detail

    Table 53. BioGaia Business Overview

    Table 54. BioGaia Human Microbiome Modulators Product

    Table 55. BioGaia Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 56. BioGaia Recent Development

    Table 57. Chr. Hansen Holding Company Detail

    Table 58. Chr. Hansen Holding Business Overview

    Table 59. Chr. Hansen Holding Human Microbiome Modulators Product

    Table 60. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 61. Chr. Hansen Holding Recent Development

    Table 62. DowDuPont Company Detail

    Table 63. DowDuPont Business Overview

    Table 64. DowDuPont Human Microbiome Modulators Product

    Table 65. DowDuPont Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 66. DowDuPont Recent Development

    Table 67. Ingredion Company Detail

    Table 68. Ingredion Business Overview

    Table 69. Ingredion Human Microbiome Modulators Product

    Table 70. Ingredion Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 71. Ingredion Recent Development

    Table 72. ISOThrive Company Detail

    Table 73. ISOThrive Business Overview

    Table 74. ISOThrive Human Microbiome Modulators Product

    Table 75. ISOThrive Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 76. ISOThrive Recent Development

    Table 77. Jarrow Formulas Company Detail

    Table 78. Jarrow Formulas Business Overview

    Table 79. Jarrow Formulas Human Microbiome Modulators Product

    Table 80. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 81. Jarrow Formulas Recent Development

    Table 82. DSM Company Detail

    Table 83. DSM Business Overview

    Table 84. DSM Human Microbiome Modulators Product

    Table 85. DSM Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 86. DSM Recent Development

    Table 87. Lallemand Company Detail

    Table 88. Lallemand Business Overview

    Table 89. Lallemand Human Microbiome Modulators Product

    Table 90. Lallemand Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 91. Lallemand Recent Development

    Table 92. Sanofi Company Detail

    Table 93. Sanofi Business Overview

    Table 94. Sanofi Human Microbiome Modulators Product

    Table 95. Sanofi Revenue in Human Microbiome Modulators Business (2018-2023) & (US$ Million)

    Table 96. Sanofi Recent Development

    Table 97. Research Programs/Design for This Report

    Table 98. Key Data Information from Secondary Sources

    Table 99. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Human Microbiome Modulators Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Human Microbiome Modulators Market Share by Type: 2022 VS 2029

    Figure 3. Probiotics and Creams Features

    Figure 4. Prebiotics and Dietary Supplements Features

    Figure 5. Drugs Features

    Figure 6. Global Human Microbiome Modulators Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Human Microbiome Modulators Market Share by Application: 2022 VS 2029

    Figure 8. Digestive Health Case Studies

    Figure 9. Immune Health Case Studies

    Figure 10. Oral Health Case Studies

    Figure 11. Others Case Studies

    Figure 12. Human Microbiome Modulators Report Years Considered

    Figure 13. Global Human Microbiome Modulators Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Human Microbiome Modulators Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Human Microbiome Modulators Market Share by Region: 2022 VS 2029

    Figure 16. Global Human Microbiome Modulators Market Share by Players in 2022

    Figure 17. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2022

    Figure 19. North America Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Human Microbiome Modulators Market Share by Country (2018-2029)

    Figure 21. United States Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Human Microbiome Modulators Market Share by Country (2018-2029)

    Figure 25. Germany Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Human Microbiome Modulators Market Share by Region (2018-2029)

    Figure 33. China Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Human Microbiome Modulators Market Share by Country (2018-2029)

    Figure 41. Mexico Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Human Microbiome Modulators Market Share by Country (2018-2029)

    Figure 45. Turkey Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Human Microbiome Modulators Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 48. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 49. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 50. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 51. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 52. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 53. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 54. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 55. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 56. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed